tirzepatide discontinuation weight regain study Trajectory of the body after drug in the treatment of anti-obesity medications | BMC Medicine Reasons for Discontinuation of Obesity

During 2024, the drugs popularity hit an all-time high, according to Tricia Rodriguez, a principal applied scientist at Truveta, which studies medical records of 120 million Americans, or about a third of the population

Both injectable approaches offer safe and effective results, but work differently

However, like any medical treatment, there can be some side effects, such as mild discomfort at the injection site, allergic reactions, or gastrointestinal issues

The FDA has warned about unapproved GLP-1 products sold online and has noted concerns that illegally marketed products may be counterfeit, may contain incorrect or harmful ingredients, or may contain too little, too much, or none of the claimed active ingredients

Because TB-500 distributes systemically regardless of injection site, there is no requirement to inject near the injury